These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 5617943)

  • 21. [Local application of corticosteroids in aimed treatment of pulmonary tuberculosis].
    Arch F
    Med Monatsschr; 1972 Jan; 26(1):32-6. PubMed ID: 5022581
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical activity of cycloserine in the treatment of pulmonary tuberculosis.
    Jimenez M
    Scand J Respir Dis Suppl; 1970; 71():172-3. PubMed ID: 5271980
    [No Abstract]   [Full Text] [Related]  

  • 23. [Methods of therapy of patients with chronic destructive pulmonary tuberculosis].
    Utkin VV; Rudoĭ NM
    Klin Med (Mosk); 1968 Dec; 46(12):36-43. PubMed ID: 5737381
    [No Abstract]   [Full Text] [Related]  

  • 24. Double blind trial with cycloserine in salvage cases of pulmonary tuberculosis.
    Viswanathan R
    Scand J Respir Dis Suppl; 1970; 71():148-51. PubMed ID: 4917143
    [No Abstract]   [Full Text] [Related]  

  • 25. [Aspects of blood coagulation in the course of antituberculosis therapy with cycloserine].
    Ceriana G; Ferrari GP
    Minerva Med; 1969 Jun; 60(50):2487-93. PubMed ID: 5792415
    [No Abstract]   [Full Text] [Related]  

  • 26. [The results of treatment with minor drugs, i.e. kanamycin, ethionamide and cycloserine, for severe pulmonary tuberculosis patients discharging bacilli resistant to all the three major drugs].
    Matsumoto M; Izumi K; Kamima H; Hirose H; Saito M
    Kekkaku; 1966 Jan; 41(1):39-46. PubMed ID: 5962711
    [No Abstract]   [Full Text] [Related]  

  • 27. [Cycloserine content of the blood serum and its urinary excretion in tuberculosis].
    Korotaev GA; Tatarinova NV
    Ter Arkh; 1972 Feb; 44(2):81-4. PubMed ID: 5039707
    [No Abstract]   [Full Text] [Related]  

  • 28. [The therapy of pulmonary tuberculosis in psychopathic patients, using terizidone].
    Micheletti V; Teti V; Fenzi P; Usberti G
    Minerva Med; 1968 May; 59(42):2459-65. PubMed ID: 5653337
    [No Abstract]   [Full Text] [Related]  

  • 29. Efficacy and safety of kanamycin, ethionamide, PAS and cycloserine in multidrug-resistant pulmonary tuberculosis patients.
    Prasad R; Verma SK; Sahai S; Kumar S; Jain A
    Indian J Chest Dis Allied Sci; 2006; 48(3):183-6. PubMed ID: 18610675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of the inhalation of tuberculostatic aerosols on the dynamics of bacterial excretion in pulmonary tuberculosis patients].
    Protsiuk RG
    Probl Tuberk; 1983 May; (5):38-42. PubMed ID: 6408637
    [No Abstract]   [Full Text] [Related]  

  • 31. [Unmotivated suicide as a most serious complication in the treatment of pulmonary tuberculosis using D-cycloserine].
    Schumann C
    Z Tuberk Erkr Thoraxorg; 1968 Dec; 129(5):295-302. PubMed ID: 5756628
    [No Abstract]   [Full Text] [Related]  

  • 32. [Th 13-14 and PZA and CS in the treatment of chronic cavitary tuberculosis with bacterial resistance to classic antibacterial drugs].
    Zunić D
    Tuberkuloza; 1966; 18(5):429-40. PubMed ID: 16296047
    [No Abstract]   [Full Text] [Related]  

  • 33. [Use of 2d series tuberculostatic preparations for pulmonary tuberculosis patients under outpatient conditions].
    Oifabakh MI; Simonian LK
    Probl Tuberk; 1969; 47(11):16-20. PubMed ID: 5369220
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical and laboratory experiences with cycloserine.
    Jancík E; Boucková I; Janciková M; Novák M
    Scand J Respir Dis Suppl; 1970; 71():306-13. PubMed ID: 5272001
    [No Abstract]   [Full Text] [Related]  

  • 35. [Administration of reserve antitubercular drugs in a single daily dose].
    Bek E; Bukalska Z; Zachara A
    Gruzlica; 1968; 37(1):43-7. PubMed ID: 5720037
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effects of natural protease inhibitors on hemostasis and serum proteolysis blockers in patients with pulmonary tuberculosis].
    Morozova TI; Khudzik LB
    Probl Tuberk; 1993; (3):27-30. PubMed ID: 7527148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparison of various methods of administration of bronchodilator drugs given by inhalation].
    Zieliński J; Kowalski J; Walczak J
    Gruzlica; 1968 May; 36(5):455-62. PubMed ID: 4873250
    [No Abstract]   [Full Text] [Related]  

  • 38. [Cheotherapy of chronic pulmonary tuberculosis with resistant mycobacteria].
    Fegiz G
    Policlinico Prat; 1967 Oct; 74(43):1454-62. PubMed ID: 5629122
    [No Abstract]   [Full Text] [Related]  

  • 39. Neurotoxic effects of cycloserine therapy in pulmonary tuberculosis of adolescents and young adults.
    Bucco T; Meligrana G; De Luca V
    Scand J Respir Dis Suppl; 1970; 71():259-65. PubMed ID: 5271998
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of pulmonary and laryngeal tuberculosis by ultrasonic inhalations].
    Frolova RP
    Probl Tuberk; 1982 Nov; (11):69-70. PubMed ID: 7156109
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.